EA produces concurrent analgesic and antidepressant effects by modulating the CREB-serotonin-BDNF signaling axis in the anterior cingulate cortex and spinal cord regions in murine models of chronic neuropathic pain comorbidity with depression-like behaviors.[165]. Here, CREB1 is linked to depressive disorder.